<html>
<head>PUBMED IDs for KAZALD1</head>
<body bgcolor='#C5F0F2'><h1>KAZALD1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19887624/'>Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.</a> December 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22836805/'>Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma.</a> February 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22836761/'>Comparative ocular microbial communities in humans with and without blepharitis.</a> October 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24002581/'>Epigenetic silencing of KAZALD1 confers a better prognosis and is associated with malignant transformation/progression in glioma.</a> April 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25257335/'>Novel interstitial deletion of 10q24.3-25.1 associated with multiple congenital anomalies including lobar holoprosencephaly, cleft lip and palate, and hypoplastic kidneys.</a> July 15  2014<br></body></html>
